Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
3SBio Inc (1530 HK)
Watchlist
87
Analysis
Health Care
•
China
3SBio, Inc. is a biotechnology company located in China. The Company focuses on mammalian cell-based biopharmaceuticals in the biotechnology industry. 3SBio also develops, manufactures and markets biopharmaceutical products globally.
more
Watchlist
Filings
Presentations
Events
Refresh
Company Event •
26 Aug 2021 09:30 • Latest
1H21 Earnings Call
Location:
Hong Kong
1H21 Earnings Call
Speakers
Zhenping Zhu (President of Drug Development, Chief Scientific Officer, 3SBio Inc.)
Fei Wang (Chief Financial Officer, 3SBio Inc.)
Jing Lou (Chairman, Chief Executive Officer, 3SBio Inc.)
Company Event •
28 Jul 2021 16:00
Recent Operational Update
Location:
Hong Kong
Recent Operational Update
Company Event •
31 Mar 2021 09:30
2020 Annual Results Announcement Investor and Analyst Presentation
Location:
Hong Kong
2020 Annual Results Announcement Investor and Analyst Presentation
Speakers
Jing Lou (Chairman & Chief Executive Officer, 3SBio Inc.)
Zhenping Zhu (President of Drug Development, Chief Scientific Officer, 3SBio Inc.)
Fei Wang (Chief Financial Officer, 3SBio Inc.)
Lu Xia (Director of Investor Relations, 3SBio Inc.)
Ziyi Chen (China Healthcare Analyst, Goldman Sachs (Asia) LLC)
Company Event •
18 Aug 2020 09:30
3SBio (1530 HK) - 1H 2020 Results Briefing (Mandarin)
Location:
Hong Kong
3SBio (1530 HK) - 1H 2020 Results Briefing (Mandarin)
Speakers
Dr. Jing LOU (Chairman & Chief Executive Officer, 3SBio Inc.)
Fei WANG (Chief Financial Officer, 3SBio Inc.)
Lu XIA (Director of Investor Relations, 3SBio Inc.)
Analysts
Li Jian (Executive Director, China International Capital Corporation)
Duration
Presentation: 19 minutes
Q&A: 19 minutes
No more events
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x